Announcements Trials
Browse Landscape

Phase

Phase 1 3Phase 3 1Phase 2/3 1Phase 2 1

Status

Active not recruiting 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Squamous Cell Carcinoma of Head and Neck 3Oropharyngeal Neoplasms 3Nasopharyngeal Carcinoma 2Carcinoma 2Renal Pelvis and Ureter Urothelial Carcinoma 1Osteosarcoma 1NSCLC 1Mouth Neoplasms 1Lymphoid Interstitial Pneumonia 1Laryngeal Neoplasms 1Hypopharyngeal Neoplasms 1Gallbladder Neoplasms 1Epstein-Barr Virus Infections 1Carcinoma, Squamous Cell 1

Interventions

Gemcitabine 5Cisplatin 5Oxaliplatin 2pertuzumab 1durvalumab 1Trastuzumab 1Standard of Care 1Radiotherapy, Intensity-Modulated 1Platinum 1Paclitaxel 1Magnetic Resonance Spectroscopy 1Lymph Node Excision 1Laparoscopy 1Geriatric Assessment 1Everolimus 1Drug Therapy 1Chemoradiotherapy 1Capecitabine 1ARRY-334543 1130-nm albumin-bound paclitaxel 11,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2/3 × Gallbladder Neoplasms × Platinum × Clear all
NCT04559139 2026-05-01

Comparison of Chemotherapy Before and After Surgery Versus After Surgery Alone for the Treatment of Gallbladder Cancer

Eastern Cooperative Oncology Group

Phase 2/3 Active not recruiting
186 enrolled
Gastrointestinal

Gallbladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡